These cells tested positive for CD10, CD79a, PAX-5, BCL-2, BCL-6 (10-20%), and c-MYC (Supplementary Figures S3B–G), but most tumor cells were negative for CD20 (Figure 2E) on immunohistochemistry. Here, BCL2 is linked to neoplasm.